A vague releasewill not strengthen a stock price. Potential investors want more than general statements.
How exactly does testing in China, Macau, etc. impact SCRN?
How much has testing by SCRN increased, or is expected to increase with the new variant?
Current numbers as well as projected numbers would provide a somewhat more solid base
for anyone considering a stock purchase here.
I am expecting/hoping for more to come our way.